Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 20, 2013

Amarin, Bristol-Myers Squibb, Cellceutix, FibroGen, MicuRx, Pfizer, Ultragenyx

Phase II
FibroGen begins IPF trial enrollment . . . read more

MicuRx expands antibiotic program . . . read more

Ultragenyx posts topline results in HIBM trial . . . read more

Filings
Amarin sNDA review delayed . . . read more

Cellceutix files for Orphan designation for mucositis treatment . . . read more

Eliquis sNDA Accepted by FDA . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters